Moderna | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
Acadia Pharmaceuticals USD 237.8M 72.86M 2024-12
Adcock Ingram Holdings ZAR 1.61B 802K 2024-06
Agios Pharmaceuticals USD 9.47M 1.29M 2024-12
Alnylam Pharmaceuticals USD 490.35M 75.33M 2024-12
Amgen USD 5.97B 781M 2024-12
Arrowhead Research -173085000 2.55M 2024-12
Biogen USD 1.87B 44.1M 2024-12
BioMarin Pharmaceutical USD 611.17M 53.89M 2024-12
Celltrion KRW 463.41B 95.59B 2024-09
Cspc Pharmaceutical CNY 4.33B 828.42M 2024-09
Gilead Sciences USD 5.99B 17M 2024-12
GlaxoSmithKline GBP 5.56B 57M 2024-12
Incyte USD 1.1B 38.34M 2024-12
Ionis Pharmaceuticals USD 222.75M 90M 2024-12
Kangmei Pharma CNY 176.17M 370.88K 2024-09
Knight Therapeutics CAD 45.02M 2.32M 2024-09
Laboratorios Farma EUR 282.36M 172.04M 2024-12
Malin Corporation EUR 3.8M 2.6M 2020-12
Moderna USD 420M 1.14B 2024-12
Organigram Holdings CAD 1.05M 67.34M 2024-12
Pharma Mar EUR 47.05M 3.4M 2024-12
Qiagen NV USD 349.8M 19.17M 2024-12
Regeneron Pharmaceuticals USD 3.22B 1.88B 2024-12
Sarepta Therapeutics USD 526.11M 150.63M 2024-12
Sartorius EUR 345.1M 43.2M 2024-09
Sino Biopharmaceutical CNY 10.5B 3.99B 2024-12
Tilray USD 61.22M 1.51M 2024-11
Ultragenyx Pharmaceutical USD 147.98M 29.51M 2024-12
United Therapeutics USD 660M 5.8M 2024-12
Vertex Pharmaceuticals USD 2.49B 109.3M 2024-12
Zz Pientze Pharmaceu 1.29B 268M 2024-09



Moderna Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.